tiprankstipranks
AegirBio AB (DE:52Q0)
FRANKFURT:52Q0
Germany Market
52Q0
AegirBio AB
RESEARCH TOOLSreports

AegirBio AB (52Q0) Financial Statements

0 Followers

AegirBio AB Financial Overview

AegirBio AB's market cap is currently €6.64M. The company's EPS TTM is €-0.1098; its P/E ratio is -0.34; AegirBio AB is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 204.39Mkr 203.76Mkr 92.00Kkr 1.71Mkr 13.28M
Gross Profitkr 75.16Mkr -14.27Mkr 44.00Kkr -23.71Mkr 5.51M
Operating Incomekr -129.21Mkr -36.55Mkr -56.16Mkr -91.48Mkr -83.76M
EBITDAkr -104.63Mkr -27.02Mkr -34.67Mkr -351.78Mkr -74.20M
Net Incomekr -88.88Mkr -49.63Mkr -59.70Mkr -362.83Mkr -92.33M
Balance Sheet
Cash & Short-Term Investmentskr 18.74Mkr 283.00Kkr 12.14Mkr 14.59Mkr 34.03M
Total Assetskr 617.77Mkr 32.61Mkr 53.10Mkr 66.87Mkr 404.37M
Total Debtkr 102.41Mkr 45.48Mkr 32.72Mkr 7.58Mkr 9.83M
Net Debtkr 83.67Mkr 45.20Mkr 20.58Mkr -7.43Mkr -24.20M
Total Liabilitieskr 200.62Mkr 71.25Mkr 54.55Mkr 27.04Mkr 33.95M
Stockholders' Equitykr 418.65Mkr -38.65Mkr -1.45Mkr 39.83Mkr 370.42M
Cash Flow
Free Cash Flowkr -20.59Mkr -12.58Mkr -47.52Mkr -49.06Mkr -109.37M
Operating Cash Flowkr -12.56Mkr -12.57Mkr -41.99Mkr -49.00Mkr -109.37M
Investing Cash Flowkr -66.47Mkr -15.55Mkr -5.54Mkr -65.00Kkr 1.60M
Financing Cash Flowkr 89.26Mkr 16.24Mkr 45.05Mkr 29.26Mkr 130.25M
Currency in SEK

AegirBio AB Earnings and Revenue History

Income Statement >

AegirBio AB Debt to Assets

Balance Sheet >

AegirBio AB Cash Flow

Cash Flow >

AegirBio AB Forecast EPS vs Actual EPS

Earnings >